Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

rights

This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi. ... The deal covers US rights to AZ’s already-marketed antibody Synagis (palivizumab), which is the only approved prophylaxis against the virus – as well as profit sharing for follow-up

Latest news

  • The Final Frontier The Final Frontier

    cannabis in the right patients for the right illnesses. ... Right behind opioids and gabapentin. We don’t need to talk about opioids – everyone knows the destruction they have caused.

  • The Midas Touch The Midas Touch

    This is understandable but not necessarily right. Small, smart money invested thoughtfully in the right place can make as good, or better, a return at low levels of risk - our business

  • Roche’s new flu pill Xofluza approved in US Roche’s new flu pill Xofluza approved in US

    Discovered and developed by Shionogi, the drug is already approved in Japan, with Roche holding the marketing rights outside Japan and Taiwan.

  • AZ swells immuno-oncology pipeline with Innate deal AZ swells immuno-oncology pipeline with Innate deal

    It looks like AZ is impressed with the potential of monalizumab to improve the activity of its checkpoint inhibitor, and it now wants full rights to the drug in return for ... There’s also some money flowing in the other direction, as Innate is

  • Alexion targets RNAi with $637m Dicerna deal Alexion targets RNAi with $637m Dicerna deal

    Alexion has also committed $15m for exclusive rights to two, subcutaneously delivered GalXC RNAi molecules, currently in pre-clinical development, and has received an exclusive option to further develop two other

More from news
Approximately 2 fully matching, plus 1,141 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 433 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    Gelesis adds to company. Biotech Gelesis has bolstered its offering with the addition of Harry Leider (pictured top right), former chief medical officer and group vice president of pharmacy company Walgreens. ... analytics and clinical reporting

  • Weekly comms appointments Weekly comms appointments

    Sarah Winterbottom joins ROAD. Independent healthcare communications specialist ROAD has appointed Sarah Winterbottom (pictured right) as senior director. ... W2O appoints Ujwal Pyati. W2O, a network of analytics-driven, digital marketing communications

  • Novartis changes executive committee Novartis changes executive committee

    Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its

  • Building trust in our industry Building trust in our industry

    in this industry to do the right thing). ... The percentage of people who trust the pharmaceutical industry to do the right thing has fluctuated only slightly in recent years and in 2018 was only 54.

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Hamermesh (pictured right), who joins from Locust Walk Partners where he served as senior vice president, will lead the business operations and corporate development strategies for the company.

More from appointments
Approximately 0 fully matching, plus 236 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 460 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Quick links

Infographics

Multimedia